Back

Early detection and optimal management of cardiorenal metabolic syndrome to prevent heart failure in the population with coronary heart disease: results from INTERASPIRE survey

28 August 2026 (11:15 - 12:00)
Organised by: Logo
Congress Presentation Part of: Novel risk factors for atrial fibrillation Epidemiology ESC Professional Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Doctor Susan Hennessy

National Institute of Preventive Cardiology, Galway (Ireland)

5 More presentations in this session

Presentation thumbnail
Low calcium in drinking water reduces vascular endothelial cell viability and increases the risk of acute myocardial infarction
Professor M. Liu (Zhengzhou, CN)
Abstract Slides Video
Presentation thumbnail
Associations between mosaic chromosomal alterations and incident cardiovascular disease in 419,000 individuals
Doctor S. Flynn (Boston, US)
Abstract Slides Video
Presentation thumbnail
The associations of periodontal disease with atrial fibrillation and heart failure: observations from a large prospective UK cohort.
Mr J. Lin (Liverpool, GB)
Abstract Slides Video
Presentation thumbnail
Joint association of clonal hematopoiesis of indeterminate potential and mosaic loss of Y chromosome with all-cause and cardiovascular mortality in men
Doctor Y. Sun (Shanghai, CN)
Abstract Slides Video
Presentation thumbnail
Sex- and age-specific distribution of a next-generation high-sensitivity cardiac troponin T assay compared to established high-sensitivity cardiac troponin T and I assays in the general population
Doctor J. Lehmacher (Hamburg, DE) Professor R. Twerenbold (Hamburg, DE)
Abstract Slides Video

Access the full session

Session thumbnail
Novel risk factors for atrial fibrillation

The Event

Event poster

ESC Congress 2026

28 August 2026 11:15 CET
You may be interested in
thumbnail
Congress Presentation
Documenting the gap between current European practice in secondary prevention and the new ESC guidelines on cardiac rehabilitation: Principal results from the EUROASPIRE VI survey in 27 countries
29 August 2026
thumbnail
Congress Presentation
Characteristics of the phenotypes of cardiovascular-renal-hepatic-metabolic syndrome in patients with chronic heart failure
31 August 2026
thumbnail
Congress Presentation
Opportunities to incorporate heart failure prevention strategies
29 August 2025
thumbnail
Congress Presentation
Defining high risk in the cardiovascular-kidney-metabolic syndrome and associated cardiovascular disease outcomes
30 August 2024

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources